Arrowhead Pharmaceuticals, Inc. (ARWR) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Arrowhead Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -2828.52x | -3.87x | -14.05x | -19.79x | -45.98x | -51.29x |
| P/B Ratio | 9.90x | 12.51x | 10.63x | 8.74x | 15.84x | 9.39x |
| P/S Ratio | 5.56x | 653.40x | 11.98x | 14.33x | 46.84x | 49.29x |
| Profitability | ||||||
| Gross Margin | 100.0% | -423.7% | 94.8% | 95.7% | 0.0% | 0.0% |
| Operating Margin | 11.9% | -16927.1% | -85.2% | -73.4% | -107.8% | -105.9% |
| Net Margin | -0.2% | -16882.4% | -85.3% | -72.4% | -101.9% | -96.1% |
| EBITDA Margin | 19.9% | -15812.8% | -73.0% | -66.7% | -95.9% | -99.1% |
| Liquidity | ||||||
| Current Ratio | 4.86x | 6.74x | 3.98x | 2.92x | 2.62x | 7.92x |
| Quick Ratio | 4.86x | 6.74x | 3.98x | 3.07x | 2.59x | 7.82x |
| Leverage | ||||||
| Debt/Equity | 0.79x | 4.59x | 1.41x | 0.20x | 0.06x | 0.05x |
YoY = year-over-year change. Source: FMP..